Follow the 원바이오젠 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 원바이오젠 has logged 15 insider filings. The latest transaction was filed on 21 November 2024 (Sale). Among the most active insiders: 교보증권. The full history is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.